Table of Content
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. At-home Drug of Abuse Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing use and production of illicit drugs
5.1.1.2. Government initiatives to reduce drug abuse
5.1.1.3. Expansion of drug production necessitates effective test measures
5.1.2. Restraints
5.1.2.1. Inability of testing products to detect small amounts of special drugs
5.1.3. Opportunities
5.1.3.1. Technological advancement and development of novel at-home drug of abuse testing devices
5.1.3.2. Investment in R&D activities for at-home drug of abuse testing devices
5.1.4. Challenges
5.1.4.1. Lack of awareness of at-home drug of abuse testing devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. At-home Drug of Abuse Testing Market, by Product
6.1. Introduction
6.2. Blood-Based Testing Kits
6.3. Breathalyzer Testing Kits
6.4. Hair-Based Testing Kits
6.5. Saliva-Based Testing Kits
6.6. Urine-Based Testing Kits
7. At-home Drug of Abuse Testing Market, by Test Type
7.1. Introduction
7.2. Cups
7.3. Strips
8. At-home Drug of Abuse Testing Market, by Drug
8.1. Introduction
8.2. Alcohol
8.3. Amphetamines
8.4. Benzodiazepines
8.5. Cocaine
8.6. Marijuana
8.7. Opioids
9. At-home Drug of Abuse Testing Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Americas At-home Drug of Abuse Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific At-home Drug of Abuse Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa At-home Drug of Abuse Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AccuBioTech Co., Ltd.
14.1.3. Accuquik by AdvaCare Pharma USA
14.1.4. Atlas Medical GmbH
14.1.5. BioMerieux, Inc.
14.1.6. Biopanda Reagents Ltd.
14.1.7. BTNX Inc.
14.1.8. Confirm BioSciences
14.1.9. Dr?gerwerk AG & Co. KGaA
14.1.10. Exploro Products
14.1.11. Identify Diagnostics by Medical Distribution Group, Inc.
14.1.12. Innovatek Medical Inc.
14.1.13. InTec Products, Inc.
14.1.14. Laboratory Corporation of America Holdings
14.1.15. McKesson Medical-Surgical
14.1.16. MyDiagnostics by Phyteos Helath Systems Inc.
14.1.17. myLAB Box Inc.
14.1.18. OraSure Technologies, Inc.
14.1.19. Phamatech Inc. by Caris Life Sciences
14.1.20. Psychemedics Corporation
14.1.21. Siemens Healthineers AG
14.1.22. Thermo Fisher Scientific Inc.
14.1.23. UCP Biosciences Inc.
14.1.24. Vitrosens Biotechnology
14.1.25. Xiamen Boson Biotech Co., Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AT-HOME DRUG OF ABUSE TESTING MARKET DYNAMICS
FIGURE 7. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 12. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. AT-HOME DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BREATHALYZER TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 12. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 15. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 40. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 44. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 62. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 66. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 74. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 98. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 111. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 115. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 119. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 123. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 127. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 135. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 147. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 151. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 155. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 171. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 183. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 193. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. AT-HOME DRUG OF ABUSE TESTING MARKET LICENSE & PRICING